Your browser doesn't support javascript.
loading
Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
Kim, Hyung Joon; Gong, Mi Kyung; Yoon, Cheol Yong; Kang, Jaeku; Yun, Mijin; Cho, Nam Hoon; Rha, Sun Young; Choi, Young Deuk.
Afiliación
  • Kim HJ; Department of Urology, Myunggok Medical Research Institute, Konyang University College of Medicine, Daejeon, Korea.
  • Gong MK; Department of Medicine, Graduate School of Yonsei University College of Medicine, Seoul, Korea.
  • Yoon CY; School of Dentistry, Pusan National University, Yangsan, Korea.
  • Kang J; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Yun M; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Cho NH; Department of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
  • Rha SY; Department of Medicine, Graduate School of Yonsei University College of Medicine, Seoul, Korea.
  • Choi YD; Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J ; 61(7): 587-596, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32608202

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_bladder_cancer Asunto principal: Neoplasias de la Vejiga Urinaria / Benzoquinonas / Cisplatino / Resistencia a Antineoplásicos / Lactamas Macrocíclicas / Inhibidores de Proteínas Quinasas / Serina-Treonina Quinasas TOR / Antineoplásicos Límite: Humans Idioma: En Revista: Yonsei Med J Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_bladder_cancer Asunto principal: Neoplasias de la Vejiga Urinaria / Benzoquinonas / Cisplatino / Resistencia a Antineoplásicos / Lactamas Macrocíclicas / Inhibidores de Proteínas Quinasas / Serina-Treonina Quinasas TOR / Antineoplásicos Límite: Humans Idioma: En Revista: Yonsei Med J Año: 2020 Tipo del documento: Article
...